Inmune Bio (INMB) Short term Debt (2022 - 2024)
Inmune Bio (INMB) posted Short term Debt of $2.5 million for Q3 2024, down 49.91% sequentially from $5.0 million in Q2 2024, and down 75.06% YoY from $10.0 million in Q4 2023.
Inmune Bio (INMB) Short term Debt (2022 - 2024) Analysis & Trends
Inmune Bio has reported Short term Debt for 3 years, with the latest figure at $2.5 million in Q3 2024.
- Quarterly Short term Debt fell 75.06% year-over-year to $2.5 million in Q3 2024, while the trailing twelve-month figure through Sep 2024 was $2.5 million (down 75.06% YoY) and the FY2023 annual result came in at $9.9 million, up 98.42% from the prior year.
- Short term Debt declined to $2.5 million in Q3 2024 per INMB's latest filing, from $5.0 million in the prior quarter.
- Over five years, Short term Debt peaked at $10.0 million in Q2 2023 and troughed at $2.5 million in Q3 2024.
- A 3-year average of $6.6 million and a median of $7.5 million in 2024 frame the typical range for Short term Debt.
- The sharpest annual moves came in 2023 and 2024: Short term Debt soared 300.0% in 2023, then slumped 75.06% in 2024.
- Over 3 years, Short term Debt stood at $5.0 million in 2022, then surged by 98.42% to $9.9 million in 2023, then tumbled by 74.86% to $2.5 million in 2024.
- According to Business Quant data, Short term Debt over the past three periods registered $2.5 million, $5.0 million, and $7.5 million for Q3 2024, Q2 2024, and Q1 2024 respectively.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) |
|---|---|---|---|---|
| 1 | Vertex Pharmaceuticals | 139.13 Bn | 131.28 Bn | 2.84 Bn |
| 2 | Regeneron Pharmaceuticals | 85.77 Bn | 77.77 Bn | 3.93 Bn |
| 3 | Argenx Se | 64.64 Bn | 59.46 Bn | 1.37 Bn |
| 4 | Moderna | 58.29 Bn | 53.16 Bn | 52.00 Mn |
| 5 | BeOne Medicines | 41.92 Bn | 36.82 Bn | 1.53 Bn |
| 6 | Alnylam Pharmaceuticals | 31.58 Bn | 28.28 Bn | 992.69 Mn |
| 7 | BioNTech SE | 28.12 Bn | 9.73 Bn | 668.28 Mn |
| 8 | Insmed | 27.39 Bn | 26.22 Bn | 358.27 Mn |
| 9 | Royalty Pharma | 27.27 Bn | 26.43 Bn | - |
| 10 | Inmune Bio | 61.59 Mn | 43.18 Mn | - |
Historic Data
Download Data| Date | Value |
|---|---|
| Sep 30, 2024 | 2.49 Mn |
| Jun 30, 2024 | 4.98 Mn |
| Mar 31, 2024 | 7.46 Mn |
| Dec 31, 2023 | 9.92 Mn |
| Sep 30, 2023 | 10.00 Mn |
| Jun 30, 2023 | 10.00 Mn |
| Mar 31, 2023 | 7.50 Mn |
| Dec 31, 2022 | 5.00 Mn |
| Sep 30, 2022 | 2.50 Mn |